EP1583765A4 - Compositions for treating and/or preventing diseases characterized by the presence of metal ions - Google Patents

Compositions for treating and/or preventing diseases characterized by the presence of metal ions

Info

Publication number
EP1583765A4
EP1583765A4 EP03796428A EP03796428A EP1583765A4 EP 1583765 A4 EP1583765 A4 EP 1583765A4 EP 03796428 A EP03796428 A EP 03796428A EP 03796428 A EP03796428 A EP 03796428A EP 1583765 A4 EP1583765 A4 EP 1583765A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treating
metal ions
diseases characterized
preventing diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03796428A
Other languages
German (de)
French (fr)
Other versions
EP1583765A2 (en
Inventor
Orrie Friedman
Ivan Correia
Toby Sommer
David Alan Kew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GrenPharma LLC
Original Assignee
GrenPharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GrenPharma LLC filed Critical GrenPharma LLC
Priority claimed from PCT/US2003/037037 external-priority patent/WO2004045552A2/en
Publication of EP1583765A2 publication Critical patent/EP1583765A2/en
Publication of EP1583765A4 publication Critical patent/EP1583765A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP03796428A 2002-11-18 2003-11-18 Compositions for treating and/or preventing diseases characterized by the presence of metal ions Withdrawn EP1583765A4 (en)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US336749P 2001-12-04
US42710402P 2002-11-18 2002-11-18
US42710502P 2002-11-18 2002-11-18
US42720302P 2002-11-18 2002-11-18
US42720102P 2002-11-18 2002-11-18
US427105P 2002-11-18
US427201P 2002-11-18
US427104P 2002-11-18
US427203P 2002-11-18
US45634503P 2003-03-20 2003-03-20
US456345P 2003-03-20
US33674903P 2003-11-17 2003-11-17
US0336749 2003-11-17
PCT/US2003/037037 WO2004045552A2 (en) 2002-11-18 2003-11-18 Compositions for treating and/or preventing diseases characterized by the presence of metal ions

Publications (2)

Publication Number Publication Date
EP1583765A2 EP1583765A2 (en) 2005-10-12
EP1583765A4 true EP1583765A4 (en) 2008-03-26

Family

ID=34916652

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03796428A Withdrawn EP1583765A4 (en) 2002-11-18 2003-11-18 Compositions for treating and/or preventing diseases characterized by the presence of metal ions

Country Status (1)

Country Link
EP (1) EP1583765A4 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314724A1 (en) * 1975-06-16 1977-01-14 Dow Corning ANTI-CONVULSORY MEDICINAL PRODUCT CONTAINING DIPHENYLSILANE
FR2335232A1 (en) * 1975-12-15 1977-07-15 Dow Corning PHARMACEUTICAL COMPOSITIONS WITH ANTI-CONVULSIVE PROPERTIES CONTAINING PHENYLSILANES
EP0273266A2 (en) * 1986-12-17 1988-07-06 Dow Corning Corporation Medicament containing a silicon derivative of menthol
FR2645863A1 (en) * 1989-04-12 1990-10-19 Voisin Philippe Silicon compounds and process for the manufacture thereof
US5523295A (en) * 1994-07-06 1996-06-04 Brandeis University Method for treating and preventing alzheimer's disease
FR2761075A1 (en) * 1997-03-24 1998-09-25 Seguin Marie Christine NOVEL BIOLOGICALLY ACTIVE SILICON-BASED COMPOUNDS AND THERAPEUTIC APPLICATIONS THEREOF
EP0877027A2 (en) * 1997-05-07 1998-11-11 Bioshield Technologies, Inc. Water-stabilized organosilane compounds and methods for using the same
US6172250B1 (en) * 1994-09-30 2001-01-09 Exsymol S.A.M. Preparation process of biologically active silicon compounds in a concentrated form
US6211393B1 (en) * 1994-09-30 2001-04-03 Exsymol S.A.M. Compounds with biologically active silicon and applications

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314724A1 (en) * 1975-06-16 1977-01-14 Dow Corning ANTI-CONVULSORY MEDICINAL PRODUCT CONTAINING DIPHENYLSILANE
FR2335232A1 (en) * 1975-12-15 1977-07-15 Dow Corning PHARMACEUTICAL COMPOSITIONS WITH ANTI-CONVULSIVE PROPERTIES CONTAINING PHENYLSILANES
EP0273266A2 (en) * 1986-12-17 1988-07-06 Dow Corning Corporation Medicament containing a silicon derivative of menthol
FR2645863A1 (en) * 1989-04-12 1990-10-19 Voisin Philippe Silicon compounds and process for the manufacture thereof
US5523295A (en) * 1994-07-06 1996-06-04 Brandeis University Method for treating and preventing alzheimer's disease
US6172250B1 (en) * 1994-09-30 2001-01-09 Exsymol S.A.M. Preparation process of biologically active silicon compounds in a concentrated form
US6211393B1 (en) * 1994-09-30 2001-04-03 Exsymol S.A.M. Compounds with biologically active silicon and applications
FR2761075A1 (en) * 1997-03-24 1998-09-25 Seguin Marie Christine NOVEL BIOLOGICALLY ACTIVE SILICON-BASED COMPOUNDS AND THERAPEUTIC APPLICATIONS THEREOF
EP0877027A2 (en) * 1997-05-07 1998-11-11 Bioshield Technologies, Inc. Water-stabilized organosilane compounds and methods for using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TACKE R ET AL: "SILA-SUBSTITUTION - A USEFUL STRATEGY FOR DRUG DESIGN?", ENDEAVOUR, PERGAMON PRESS, OXFORD, GB, vol. 10, no. 4, 1986, pages 191 - 197, XP008002622, ISSN: 0160-9327 *
TACKE R ET AL: "Syntheses and properties of bioactive organo-silicon compounds.", TOPICS IN CURRENT CHEMISTRY 1979, vol. 84, 1979, pages 1 - 75, XP002463246, ISSN: 0340-1022 *

Also Published As

Publication number Publication date
EP1583765A2 (en) 2005-10-12

Similar Documents

Publication Publication Date Title
EP1711197A4 (en) Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
AU2002364364A8 (en) Method of treating apoptosis and compositions thereof
HK1152474A1 (en) Methods and compositions for the prevention and treatment of sepsis
EP1416961A4 (en) Composition and method for the treatment of disease
EP1617805A4 (en) Methods of preventing or treating respiratory conditions
HUP0402629A3 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
HRP20040906B1 (en) Bisphosphonic acid for the treatment and prevention of ostreoporosis
EP1755537A4 (en) Methods and compositions for preventing or treating periodontal diseases
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
HUP0402421A3 (en) Composition inhibiting matrix-metalloproteinases for the treatment of neoplastic diseases
EP1492902A4 (en) Composition and process for the treatment of metal surfaces
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
EP1450820A4 (en) Method for treating or preventing inflammatory diseases
PL368035A1 (en) Compositions and methods for the treatment of cancer
IL155111A0 (en) Pharmaceutical compositions for inhibiting metal ion dependent enzymatic activity and methods for the use thereof
IL145397A0 (en) Compositions and methods for treatment of cancer
EP1575497A4 (en) Novel composition and methods for the treatment of psoriasis
AU2003291730A8 (en) Methods and compositions for treating neurodegenerative diseases
EP1583765A4 (en) Compositions for treating and/or preventing diseases characterized by the presence of metal ions
IL182700A0 (en) Compositions for treating and/or preventing diseases characterized by the presesnce of metal ions
AU2003265281A8 (en) Methods and compositions for the enhancement of wound healing
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
AU2002305823A1 (en) Cancer treatment method and compositions comprising compounds of the ginger family

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050531

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080227

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/28 20060101ALI20080219BHEP

Ipc: A61K 31/695 20060101ALI20080219BHEP

Ipc: C07F 7/00 20060101AFI20080219BHEP

17Q First examination report despatched

Effective date: 20080619

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081230